7-Ethoxyresorufin
CAS No. 5725-91-7
7-Ethoxyresorufin( Resorufin ethyl ether )
Catalog No. M27419 CAS No. 5725-91-7
7-Ethoxyresorufin (7-ER) is a fluorometric substrate for and competitive inhibitor of cytochrome P450, especially CYP1A1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 36 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 96 | In Stock |
|
| 25MG | 196 | In Stock |
|
| 50MG | 343 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name7-Ethoxyresorufin
-
NoteResearch use only, not for human use.
-
Brief Description7-Ethoxyresorufin (7-ER) is a fluorometric substrate for and competitive inhibitor of cytochrome P450, especially CYP1A1.
-
Description7-Ethoxyresorufin (7-ER) is a fluorometric substrate for and competitive inhibitor of cytochrome P450, especially CYP1A1.(In Vivo):7-ER inhibited responses to NO and nitrergic nerve stimulation through generation of superoxide radicals. A 7-ER sensitive P450 system may be involved in the bioactivation of GTN and SNP in rat aortic rings, but not in rabbit aorta or rat anococcygeus muscles.
-
In Vitro——
-
In Vivo——
-
SynonymsResorufin ethyl ether
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5725-91-7
-
Formula Weight241.246
-
Molecular FormulaC14H11NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMF : 2 mg/mL (8.29 mM )
-
SMILESCCOc1ccc2nc3ccc(=O)cc3oc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Molnar J, et al. Antimicrobial and immunomodulating effects of some phenolic glycosides. Acta Microbiol Hung. 1989;36(4):425-32.
molnova catalog
related products
-
LY 43578
LY 43578 is an orally active aromatase inhibitor. LY43578 could inhibit O-demethylation of P-450-dependent p-nitroanisole and N-demethylation of ethylmorphine (IC50 of 0.3 and 5 μm, respectively) in rat liver microsomes.
-
CDD3506
CDD3506 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
-
TAK-700 (Orteronel)
Orteronel(TAK-700) was selected as a candidate for clinical evaluation.
Cart
sales@molnova.com